Yangzhou Huitong Bio’s 30,000‑ton‑per‑year polylactic acid (PLA) chip production facility has successfully completed its first trial run with feedstock, achieving a key milestone.
Release date:
2025-12-15

In December 2025, Yangzhou Huitong Bio‑New Materials Co., Ltd. conducted the first feed trial run of its 30,000‑ton‑per‑year polylactic acid (PLA) pelletizing plant. The trial utilized Huitong Technology’s independently developed lactide production process and key equipment, as well as Sulzer’s purification and polymerization equipment and technologies, achieving end‑to‑end integration of the entire process flow.
The recent trial run with feedstock has yielded preliminary results. At present, the company’s specialized technical team is conducting a comprehensive review and in-depth root-cause analysis of the minor issues identified during the trial. Going forward, a targeted corrective action plan will be developed, and through ongoing technical validation, parameter optimization, and process refinement, product quality and stability will be enhanced.


The phased achievements attained during this facility’s initial trial run mark a new starting point for the company’s development, while subsequent upgrades and optimizations represent a fresh journey toward higher-quality growth. Seizing this opportunity, the company will continue to deepen its expertise in differentiated polylactic acid (PLA) pellets, focusing on niche market demands such as high-value-added textile applications, advanced medical uses, and 3D printing. By collaborating with both longstanding and new partners across the industry chain, we will work together to create synergies and make greater contributions to building green, next-generation productive forces in the new era.
Related News